Patent · US Active

Anti-TIGIT antibodies and methods of use

US10047158B2 · kind B2 · utility

6Cited by
11References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 13, 2018
Grant dateAug 14, 2018
Priority date
Expiry dateFeb 13, 2038

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides anti-TIGIT (T-cell immunoreceptor with Ig and ITIM domains) antibodies and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.